Weidong Xiao, PhD
Affiliations: | Temple University, Philadelphia, PA, United States |
Google:
"Weidong Xiao"Parents
Sign in to add mentor| Jude Samulski | grad student | UNC Chapel Hill | |
| James M. Wilson | grad student | Penn |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang J, Frabutt DA, Chrzanowski M, et al. (2024) A novel class of self-complementary AAV vectors with multiple advantages based on cceAAV lacking mutant ITR. Molecular Therapy. Methods & Clinical Development. 32: 101206 |
| Lam AK, Mulcrone PL, Frabutt D, et al. (2023) Comprehensive Comparison of AAV Purification Methods: Iodixanol Gradient Centrifugation vs. Immuno-Affinity Chromatography. Advances in Cell and Gene Therapy. 2023 |
| Xiao W, Gao G, Ling C, et al. (2018) Impact of neutralizing antibodies against AAV is a key consideration in gene transfer to nonhuman primates. Nature Medicine |
| Wang Q, Wu Z, Zhang J, et al. (2017) A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors. Molecular Therapy. Methods & Clinical Development. 7: 146-156 |
| Yin C, Zhang T, Qu X, et al. (2017) In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Moore AR, Dong B, Chen L, et al. (2015) Vaccinia virus as a subhelper for AAV replication and packaging. Molecular Therapy. Methods & Clinical Development. 2: 15044 |
| Wang Q, Dong B, Firrman J, et al. (2014) Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery. Human Gene Therapy Methods. 25: 261-8 |
| Dong B, Moore AR, Dai J, et al. (2013) A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy. Nucleic Acids Research. 41: 6609-17 |
| Diao Y, Wang Q, Xiao W, et al. (2011) [Recombinant adeno-associated virus vector related impurities]. Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology. 27: 717-23 |
| Lu H, Qu G, Yang X, et al. (2011) Systemic elimination of de novo capsid protein synthesis from replication-competent AAV contamination in the liver. Human Gene Therapy. 22: 625-32 |